
744. studies protein nucleic acid metabolism virus-in- 
fected mammalian cells.  formation virus-specific 
antigen krebs ii ascites-tumour cells infected ence- 
phalomyocarditis virus 
krebs ii mouse ascites-tumor cells infected 
encephalomyocarditis virus 
found contain, addition mature virus, 
virus-specific protein antigen.  
assay, based ability antigen 
block neutralization purified virus 
specific antiserum, developed. 
antigen present cul- 
ture fluid 17 hr. infection cells 
virus intracellularly, 
titer increased time viral capsid 
protein synthesized.  within 
cell, mostly localized soluble 
cell sap.  contrast virus, anti- 
gen agglutinate sheep erythrocytes, 
immunological properties 
destroyed digestion trypsin.  ribonucleic 
acid detected concentrat- 
ed preparations antigen, titer 
antigen affected ribonuclease. 
antigen sedimentation coefficient (20 ) 
approx. 14s, diffusion co- 
efficient, determined method allison 
humphrey (1960), 3.2 x 10-7 
sq. cm. sec.-1.  particle weight antigen 
hence 420,000   40,000.  
capsid protein purified encephalomyocarditis 
virus degraded treat- 
ment ethanolamine protein sedimentation 
coefficient (20 ) approx. 4s. 
14s antigen, similarly treated, yielded 
protein similar size.  however, 
smaller antigen detected virus-infected 
cells.  concluded 
non-hemagglutinating antigen represents polymeric 
form basic viral capsid- 
protein molecule synthesized 
cytoplasm infected cells.  may 
either intermediate by-product 
process viral capsid-protein syn- 
thesis. 
